Previous 10 | Next 10 |
Thorne HealthTech Announces Second Quarter 2022 Earnings Release Date and Conference Call PR Newswire NEW YORK , July 19, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in developing innovative solutions for a personalized appr...
Thorne HealthTech partners with USRowing to Support the U.S. National Rowing Team PR Newswire NEW YORK , June 13, 2022 /PRNewswire/ -- USRowing is pleased to announce that Thorne HealthTech (NASDAQ: THRN) has signed on as an Official USRowing Partner and ...
Nutraceutical companies will perform well during the next decade, even during a recession. DIY health trends are on the rise. Thorne HealthTech is well-positioned to benefit from these trends. For further details see: Thorne HealthTech: Poised To Outperform Other Nutrace...
Thorne Relaunches its Gut Health Test with the First-to-Market, User-Friendly Microbiome Wipe that Revolutionizes the Testing Experience PR Newswire Thorne's innovative approach to microbiome testing through a one-of-a-kind, user friendly wipe provides users with c...
Thorne HealthTech (THRN) Q1 2022 Earnings Conference Call May 12, 2022 08:00 ET Company Participants Thomas Wilson - Vice President & Head of Investor Relations Paul Jacobson - Co-Founder & Chief Executive Officer Bryan Conley - Chief Financial Officer Michelle Crow - Chief Marketing ...
Image source: The Motley Fool. Thorne HealthTech, Inc. (NASDAQ: THRN) Q1 2022 Earnings Call May 12, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Thorne HealthTech, Inc. (THRN) Q1 2022 Earnings Call Transcript
The following slide deck was published by Thorne HealthTech, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Thorne HealthTech, Inc. 2022 Q1 - Results - Earnings Call Presentation
Thorne HealthTech press release (NASDAQ:THRN): Q1 Non-GAAP EPS of $0.12 beats by $0.02. Revenue of $54.67M (+22.9% Y/Y) misses by $1.45M. Full-year 2022 guidance reaffirmed for projected net sales of $240 million to $250 million, adjusted EPS of $0.28 to $0.30. For further details see:...
Large-Scale Surveillance Study Confirms Reliability of the OneDraw™ Blood Collection Device In Remote Blood Sample Collection at Home PR Newswire In a major research study, 4,000 participants collected their own blood samples to test for COVID-19 antibodies; 99....
Thorne HealthTech Reports First Quarter 2022 Results PR Newswire Reaffirms Full-Year 2022 Guidance NEW YORK , May 11, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or the "Company") (NASDAQ: THRN ), a leader in developi...
News, Short Squeeze, Breakout and More Instantly...
Thorne Healthtech Inc. Company Name:
THRN Stock Symbol:
NASDAQ Market:
Thorne Healthtech Inc. Website:
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Thorne Healthtech Inc. (THRN) is expected to report for Q3 2023
L Catterton Completes Acquisition of Thorne HealthTech, Inc. PR Newswire NEW YORK , Oct. 16, 2023 /PRNewswire/ -- L Catterton, a leading global consumer-focused investment firm, today announced the successful completion of its acquisition of Thorne ...